COM:THESEUSRX

Theseus Pharmaceuticals, Inc.

Stock

Last Close

4.06

13/02 20:59

Market Cap

181.50M

Beta: -

Volume Today

677.69K

Avg: -

Overview Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22
revenue
cost of revenue	2K -	2K 0%	2K 0%	438K 21,800%
gross profit	-2K -	-2K 0%	-2K 0%	-438K 21,800%
selling and marketing expenses
general and administrative expenses	818K -	878K 7.33%	9.01M 925.97%	18.39M 104.13%
selling general and administrative expenses	818K -	878K 7.33%	9.01M 925.97%	18.39M 104.13%
research and development expenses	4.12M -	5.96M 44.47%	18.33M 207.62%	35.70M 94.77%
other expenses	-2.24M -	-5.16M 130.30%	28K 100.54%	3.48M 12,321.43%
cost and expenses	4.94M -	6.84M 38.32%	27.34M 299.88%	54.09M 97.86%
operating expenses	4.94M -	6.84M 38.32%	27.34M 299.88%	54.09M 97.86%
interest expense				-3.53M -
ebitda	-4.94M -	-6.83M 38.34%	-27.33M 299.97%	-54.09M 97.87%
operating income	-4.94M -	-6.84M 38.32%	-27.34M 299.88%	-54.09M 97.86%
depreciation and amortization	2K -	2K 0%	2K 0%	50K 2,400%
total other income expenses net	-2.24M -	-5.16M 130.30%	28K 100.54%	3.48M 12,321.43%
income before tax	-7.18M -	-12.00M 67.02%	-27.31M 127.62%	-50.61M 85.32%
income tax expense				-3.53M -
net income	-7.18M -	-12.00M 67.02%	-27.31M 127.62%	-47.08M 72.40%
weighted average shs out	11.92M -	25.37M 112.87%	9.63M 62.03%	38.49M 299.61%
weighted average shs out dil	11.92M -	25.37M 112.87%	9.63M 62.03%	38.49M 299.61%
eps	-0.60 -	-0.47 21.67%	-2.84 504.26%	-1.22 57.04%
epsdiluted	-0.60 -	-0.47 21.67%	-2.84 504.26%	-1.22 57.04%

All numbers in (except ratios and percentages)